Rada Savic

2.7k total citations · 1 hit paper
49 papers, 1.4k citations indexed

About

Rada Savic is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Rada Savic has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 15 papers in Epidemiology and 11 papers in Pharmacology. Recurrent topics in Rada Savic's work include Tuberculosis Research and Epidemiology (22 papers), HIV/AIDS drug development and treatment (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Rada Savic is often cited by papers focused on Tuberculosis Research and Epidemiology (22 papers), HIV/AIDS drug development and treatment (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Rada Savic collaborates with scholars based in United States, South Africa and Uganda. Rada Savic's co-authors include Kelly E. Dooley, Payam Nahid, Katherine Fielding, Robert J. Wilkinson, U. K. Misra, Guy Thwaites, Nguyen Thi Hoang, Reinout van Crevel, Maxine Caws and Regan Solomons and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Rada Savic

46 papers receiving 1.4k citations

Hit Papers

Tuberculous meningitis 2017 2026 2020 2023 2017 50 100 150 200 250

Peers

Rada Savic
Rada Savic
Citations per year, relative to Rada Savic Rada Savic (= 1×) peers Nonhlanhla Yende‐Zuma

Countries citing papers authored by Rada Savic

Since Specialization
Citations

This map shows the geographic impact of Rada Savic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rada Savic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rada Savic more than expected).

Fields of papers citing papers by Rada Savic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rada Savic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rada Savic. The network helps show where Rada Savic may publish in the future.

Co-authorship network of co-authors of Rada Savic

This figure shows the co-authorship network connecting the top 25 collaborators of Rada Savic. A scholar is included among the top collaborators of Rada Savic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rada Savic. Rada Savic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijk, Rob C. van, Natasha Strydom, Qianwen Wang, et al.. (2025). Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data. iScience. 28(3). 111932–111932. 1 indexed citations
2.
Garcia‐Cremades, Maria, et al.. (2024). Pharmacokinetic–pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrobial Agents and Chemotherapy. 68(8). e0019024–e0019024. 1 indexed citations
3.
Wang, Qianwen, et al.. (2024). Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform. Antimicrobial Agents and Chemotherapy. 68(10). e0061524–e0061524. 1 indexed citations
4.
Li, Jing, Philip Z. Brohawn, Bo Sun, et al.. (2023). Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab. CPT Pharmacometrics & Systems Pharmacology. 12(12). 1945–1959. 5 indexed citations
5.
Strydom, Natasha, Qianwen Wang, Rob C. van Wijk, et al.. (2023). Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. European Respiratory Journal. 62(2). 2300165–2300165. 8 indexed citations
6.
Bauman, Allison, Karen Rossmassler, Martin I. Voskuil, et al.. (2022). Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrobial Agents and Chemotherapy. 66(4). e0231021–e0231021. 12 indexed citations
7.
Lü, Ying, Sandhya Kharbanda, Christopher C. Dvorak, et al.. (2022). Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation. Pharmaceutics. 14(11). 2462–2462. 6 indexed citations
8.
Rossmassler, Karen, Justin J. Reid, Rada Savic, et al.. (2022). MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assays. Journal of Pharmaceutical and Biomedical Analysis. 212. 114664–114664.
9.
Ordoñez, Alvaro A., Elizabeth W. Tucker, Carolyn J. Anderson, et al.. (2021). Visualizing the dynamics of tuberculosis pathology using molecular imaging. Journal of Clinical Investigation. 131(5). 17 indexed citations
10.
Wallender, Erika, Ali M. Ali, Emma Hughes, et al.. (2021). Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature Communications. 12(1). 6714–6714. 11 indexed citations
11.
Weiner, Marc, Jon Gelfond, Teresa L. Johnson‐Pais, et al.. (2020). Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. Journal of Antimicrobial Chemotherapy. 76(3). 582–586. 13 indexed citations
12.
Garcia‐Prats, Anthony J., H. Simon Schaaf, Heather R. Draper, et al.. (2019). Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies. PLoS Medicine. 16(4). e1002789–e1002789. 44 indexed citations
13.
Wallender, Erika, Nan Zhang, Melissa D. Conrad, et al.. (2018). Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations
14.
Imperial, Marjorie Z., Payam Nahid, Patrick Phillips, et al.. (2018). A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nature Medicine. 24(11). 1708–1715. 191 indexed citations
15.
Denti, Paolo, Anthony J. Garcia‐Prats, Heather R. Draper, et al.. (2017). Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(2). 38 indexed citations
16.
Wilkinson, Robert J., Ursula K. Rohlwink, U. K. Misra, et al.. (2017). Tuberculous meningitis. Nature Reviews Neurology. 13(10). 581–598. 287 indexed citations breakdown →
17.
Keizer, Ron J., Gordon Munro, Arne Mørk, et al.. (2016). Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model. Pharmaceutical Research. 33(5). 1133–1143. 12 indexed citations
18.
Gheyas, Ferdous, Junghoon Lee, Anne Chain, et al.. (2015). Pharmacokinetic and Pharmacokinetic/ Pharmacodynamic Modeling to Inform Optimal Dose of Vorapaxar. Journal of Pharmacokinetics and Pharmacodynamics. 42. 1 indexed citations
19.
Sheffield, Jeanne S., David Siegel, Mark Mirochnick, et al.. (2014). Designing Drug Trials: Considerations for Pregnant Women. Clinical Infectious Diseases. 59(suppl_7). S437–S444. 78 indexed citations
20.
Long-Boyle, Janel, Rada Savic, Imke H. Bartelink, et al.. (2014). Population Pharmacokinetics of Busulfan in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplant. Therapeutic Drug Monitoring. 37(2). 236–245. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026